ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 2588

$935K Total Retail Price of All Prescriptions

Rank: 108 out of 2588

649 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 649 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 13,587 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 702 642 1 1
AMLODIPINE BESYLATE 649 600 2 4
LISINOPRIL 638 528 3 3
ATORVASTATIN CALCIUM 502 438 4 11
CRESTOR 496 402 5 25
BYSTOLIC 471 421 6 110
FUROSEMIDE 466 422 7 5
METFORMIN HCL 408 333 8 8
LEVOTHYROXINE SODIUM 374 372 9 2
HYDROCHLOROTHIAZIDE 347 316 10 13
OMEPRAZOLE 332 305 11 6
HYDROCODONE-ACETAMINOPHEN 300 248 S3 12 7
WARFARIN SODIUM 297 229 13 10
TRAMADOL HCL 244 210 14 19
METOPROLOL TARTRATE 216 203 15 9
CITALOPRAM HBR 191 162 16 27
PROAIR HFA 181 143 17 50
POTASSIUM CHLORIDE 174 150 18 15
DIOVAN 171 146 19 29
ALLOPURINOL 170 141 20 33
QUINAPRIL HCL 164 148 21 148
ATENOLOL 158 158 22 14
GLYBURIDE 153 124 R 23 65
ZOLPIDEM TARTRATE 150 136 24 24
ESCITALOPRAM OXALATE 148 131 25 68
CARVEDILOL 145 119 26 20
PANTOPRAZOLE SODIUM 144 132 27 28
ENALAPRIL MALEATE 122 118 28 31
LANTUS 122 102 28 47
CLOPIDOGREL 120 106 30 30
NEXIUM 119 95 31 41
GABAPENTIN 119 101 31 18
DIOVAN HCT 116 116 33 72
PLAVIX 115 103 34 43
AZITHROMYCIN 107 94 35 45
DONEPEZIL HCL 104 104 36 22
NAMENDA 101 101 37 32
PREDNISONE 98 90 38 42
POLYETHYLENE GLYCOL 3350 98 98 38 55
SPIRIVA 98 65 38 56
MIRTAZAPINE 94 91 41 63
LEXAPRO 92 80 42 182
FLUTICASONE PROPIONATE 84 65 43 40
FELODIPINE ER 83 78 44 108
PRAVASTATIN SODIUM 81 65 45 16
INSULIN SYRINGE 81 67 45 81
LIPITOR 78 56 47 114
ADVAIR DISKUS 74 55 48 48
CYMBALTA 73 68 49 70
SYMBICORT 72 52 50 129
DIGOXIN 68 64 51 38
ISOSORBIDE MONONITRATE ER 65 61 52 49
TRAZODONE HCL 63 50 53 61
CIPROFLOXACIN HCL 63 54 53 82
BUSPIRONE HCL 62 58 55 173
SINGULAIR 60 54 56 94
TAMSULOSIN HCL 60 59 56 23
DICLOFENAC SODIUM 60 60 56 124
RANITIDINE HCL 59 49 59 37
NIASPAN 59 40 59 115
VERAPAMIL ER 57 43 61 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 62 35
SERTRALINE HCL 52 52 63 26
LEVOFLOXACIN 50 46 64 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.